Afuco™ Anti-RSV F ADCC Therapeutic Antibody (Motavizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to RSV glycoprotein F. Motavizumab is a humanized monoclonal antibody for the prevention of respiratory syncytial virus infection in high-risk infants.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-709 |
Pricing | Inquiry |
Host | Human |
Target | RSV F |
Species Reactivity | RSV |
Type | ADCC enhanced antibody |
Applications | IF, IP, Neut, FuncS, ELISA, FC |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |